Christus Vna of San Antonio San Antonio, TX - 78229

Christus Vna of San Antonio is categorized under Commercial Medical Research in San Antonio, TX and active since 2012.

Christus Vna of San Antonio was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6231101 by the NAICS.

If you are seeking more information, feel free to contact James Carlson at the company’s single location by writing to 5131 Medical Drive, San Antonio, Texas TX 78229 or by phoning (210) 558-6300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Christus Vna of San Antonio
Contact Person: James Carlson
Address: 5131 Medical Drive, San Antonio, Texas 78229
Phone Number: (210) 558-6300
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 6231101
Share This Business:

Christus Vna of San Antonio was started in 2012 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6231101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact James Carlson for inquiries that concern Christus Vna of San Antonio by calling the company number (210) 558-6300, as your correspondence is most welcome. Additionally, the physical location of the single location of Christus Vna of San Antonio can be found at the coordinates 29.510338,-98.588087 as well as the street address 5131 Medical Drive in San Antonio, Texas 78229.

For its online presence, you may visit Christus Vna of San Antonio’s website at and engage with its social media outlets through on Twitter and on Facebook.